Healionics Invested 2019

Healionics is a clinical stage company addressing the critical need for improved means of dialysis access in patients with kidney failure. The company is commercializing a synthetic vascular graft called STARgraft with superior patency (ability to maintain blood flow), based on its platform STAR biomaterial technology. The graft will initially address the urgent need for improved vascular access for hemodialysis patients, with subsequent applications to peripheral artery disease and potentially coronary artery bypass. Healionics is also developing a device to enable needle-free hemodialysis. www.Healionics.com